{
      "ptx_code": "PTX001",
      "chem_name": "Cadmium chloride",
      "casrn": "10108-64-2",
      "dtxsid": "DTXSID6020226",
      "smiles": "[Cl-].[Cl-].[Cd++]",
      "inchikey": "YKYOUMDCQGMQQO-UHFFFAOYSA-L",
      "label": "PTX001 | Cadmium chloride",
      "drugbank_id": "",
      "use_class": "Pesticide",
      "tox_class": "Cardiotoxicity; Nephrotoxicity; Genotoxicity; Hematotoxicity; Ototoxicity; Neurotoxicity; Hepatotoxicity; Immunotoxicity",
      "chem_name_user": "Cadmium chloride",
      "mw_g_mol": "183.31",
      "solubility_h2o_mol_liter": "2.493044569",
      "source_solubility_h2o": "MSDS (Sigma)",
      "henry_coefficient_atm_m3_mol": "",
      "source_henry": "",
      "log_kaw_kh_rt": "",
      "source_kaw": "",
      "pka_acid": "",
      "pka_base": "",
      "source_pka": "ACD pKa/GALAS",
      "log_kow_liter_liter": "",
      "source_kow": "",
      "log_dlipw_ph74_liter_liter": "metal",
      "source_dlipw": "",
      "freely_dissolved_fraction": "",
      "density_kg_liter": "4.05",
      "source_density": "MSDS (Sigma)",
      "baseline_drerio": "",
      "baseline_dmagna": "",
      "baseline_celegans": "",
      "baseline_xlaevis": "",
      "baseline_dmelanogaster": "",
      "baseline_cells": "",
      "baseline_cells_generic_micromole_liter_free_ec10": "",
      "moa_drugbank": "",
      "protein_binding": "",
      "moa_t3db": "Cadmium causes cell apoptosis by activating mitogen-activated protein kinases. (A28); Cadmium binds to and activates the estrogen receptor, likely stimulating the growth of certain types of cancer cells and causing other estrogenic effects, such as reproductive dysfunction. (A19)",
      "aop": [
            {
                  "AOP_id": 6,
                  "AOP_name": "Antagonist binding to PPAR\u03b1 leading to body-weight loss "
            },
            {
                  "AOP_id": 18,
                  "AOP_name": "PPAR\u03b1 activation in utero leading to impaired fertility in males "
            },
            {
                  "AOP_id": 19,
                  "AOP_name": "Androgen receptor antagonism leading to adverse effects in the male foetus (mammals) "
            },
            {
                  "AOP_id": 34,
                  "AOP_name": "LXR activation leading to hepatic steatosis "
            },
            {
                  "AOP_id": 36,
                  "AOP_name": "Peroxisomal Fatty Acid Beta-Oxidation Inhibition Leading to Steatosis "
            },
            {
                  "AOP_id": 57,
                  "AOP_name": "AhR activation leading to hepatic steatosis "
            },
            {
                  "AOP_id": 58,
                  "AOP_name": "NR1I3 (CAR) suppression leading to hepatic steatosis "
            },
            {
                  "AOP_id": 61,
                  "AOP_name": "NFE2L2/FXR activation leading to hepatic steatosis "
            },
            {
                  "AOP_id": 72,
                  "AOP_name": "Epigenetic modification of PPARG leading to adipogenesis "
            },
            {
                  "AOP_id": 123,
                  "AOP_name": "Unknown MIE leading to reproductive dysfunction via increased HIF-1alpha transcription "
            },
            {
                  "AOP_id": 131,
                  "AOP_name": "Aryl hydrocarbon receptor activation leading to uroporphyria "
            },
            {
                  "AOP_id": 148,
                  "AOP_name": "EGFR Activation Leading to Decreased Lung Function "
            },
            {
                  "AOP_id": 154,
                  "AOP_name": "Inhibition of Calcineurin Activity Leading to Impaired T-Cell Dependent Antibody Response "
            },
            {
                  "AOP_id": 187,
                  "AOP_name": "Anticoagulant rodenticide inhibition of vitamin K epoxide reductase resulting coagulopathy and hemorrhage "
            },
            {
                  "AOP_id": 200,
                  "AOP_name": "Estrogen receptor activation leading to breast cancer   "
            },
            {
                  "AOP_id": 318,
                  "AOP_name": "Glucocorticoid Receptor activation leading to hepatic steatosis "
            }
      ],
      "targets": [
            "Androgen receptor",
            "C-Jun-amino-terminal kinase-interacting protein 1",
            "C-Jun-amino-terminal kinase-interacting protein 2",
            "C-Jun-amino-terminal kinase-interacting protein 3",
            "C-Jun-amino-terminal kinase-interacting protein 4",
            "Estrogen receptor alpha",
            "Estrogen receptor beta",
            "Mitogen-activated protein kinase 1",
            "Mitogen-activated protein kinase 10",
            "Mitogen-activated protein kinase 11",
            "Mitogen-activated protein kinase 12",
            "Mitogen-activated protein kinase 13",
            "Mitogen-activated protein kinase 14",
            "Mitogen-activated protein kinase 15",
            "Mitogen-activated protein kinase 3",
            "Mitogen-activated protein kinase 4",
            "Mitogen-activated protein kinase 6",
            "Mitogen-activated protein kinase 7",
            "Mitogen-activated protein kinase 8",
            "Mitogen-activated protein kinase 9",
            "Sodium-coupled neutral amino acid transporter 1",
            "Sodium-dependent noradrenaline transporter"
      ]
}